EMLA (LIDOCAINE; PRILOCAINE) — FDA Approval NDA020962 (ASTRAZENECA)
EMLA (LIDOCAINE; PRILOCAINE) — FDA Approval NDA020962 (ASTRAZENECA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: EMLA; Active ingredients: LIDOCAINE; PRILOCAINE; Application number: NDA020962.
| Brand name | EMLA |
|---|---|
| Active ingredients | LIDOCAINE; PRILOCAINE |
| Application number | NDA020962 |
| Sponsor | ASTRAZENECA |
| Dosage form | DISC |
| Route | TOPICAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19980204 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →